The U.S. Food and Drug Administration has drawn a clear line: leucovorin, a form of folate long discussed in autism circles, was approved for a specific, rare brain disorder but not endorsed as a treatment for autism. The agency’s recent ruling has stirred debate among clinicians, families and researchers about …